# Nuclear Myosin VI - a Therapeutic Target in Breast Cancer

> **NCT03430024** · — · UNKNOWN · sponsor: **Maidstone & Tunbridge Wells NHS Trust** · enrollment: 120 (estimated)

## Conditions studied

- Breast Cancer

## Interventions

- **OTHER:** Association of Myosin VI with oestrogen receptor

## Key facts

- **NCT ID:** NCT03430024
- **Lead sponsor:** Maidstone & Tunbridge Wells NHS Trust
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2019-05-05
- **Primary completion:** 2020-12
- **Final completion:** 2020-12
- **Target enrollment:** 120 (ESTIMATED)
- **Last updated:** 2019-11-13

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03430024

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03430024, "Nuclear Myosin VI - a Therapeutic Target in Breast Cancer". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT03430024. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*